Blastomyces dermatitidis Gilchrist et Stokes, anamorph
Strain Designations
A
Alternate State
Ajellomyces dermatitidis McDonough et Lewis
Application
Biomedical Research and Development Material
Emerging infectious disease research
Biosafety Level
3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Type Strain
no
Preceptrol®
no
Comments
characterization
Medium
ATCC® Medium 28: Emmons' modification of Sabouraud's agar
Growth Conditions
Temperature: 37.0°C
Name of Depositor
DA Stevens
Chain of Custody
ATCC <<--DA Stevens<<--C. Brass
Isolation
attenuated mutant derived from ATCC 26199
References
Brass C, et al. Spontaneous mutant of Blastomyces dermatitidis attenuated in virulence for mice. Sabouraudia 20: 145-158, 1982. PubMed: 7112336
Hogan LH, Klein BS. Transforming DNA integrates at multiple sites in the dimorphic fungal pathogen Blastomyces dermatitidis. Gene 186: 219-226, 1997. PubMed: 9074500
